Table of Contents
Description
Collaborative Research to Action in Dementia grants will support knowledge translation research and related activities involving Canadian, and where relevant foreign, researchers, initiatives and networks in the fields of Alzheimer Disease and related Dementias.
This joint effort is launched under the Cognitive Impairment in Aging Partnership Initiative and builds on the network funded under the Research to Action Program in Dementia: the Canadian Dementia Knowledge Translation Network.
Funds Available
CIHR's contribution to the amount available for this initiative is subject to availability of funds voted annually to CIHR by parliamentary appropriations, and the conditions that may be attached to them.
- The total amount available for this initiative is $500,000 for a one-year period. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single Collaborative Research to Action in Dementia grant is $100,000 for one year. The equipment amount is awarded in year one.
- The funding will be granted by the CIHR Institute of Aging.
For more information, please consult the Alzheimer Society of Canada website.
Top
Objectives
The purpose of this joint Collaborative Research to Action in Dementia grant funding opportunity is to promote national and international collaborations aimed at accelerating the translation of research in the fields of Alzheimer Disease and related Dementias into improved diagnosis, treatment and care. More specifically it will:
- stimulate and strengthen alliances within Canada and with other nations (their researchers, research institutes or governments) that have a shared interest in the application of research in Alzheimer Disease and related Dementias; and
- develop longer-term, collaborative national and international efforts focused on Alzheimer Disease and related Dementias research and/or its application.
Top
Eligibility
Researchers, research and research-related activities will be considered eligible for Collaborative Research to Action in Dementia grants if the following criteria are met:
Eligibility criteria for all CIHR research funding programs apply. The business office of the institution of an eligible Nominated Principal Applicant generally administers CIHR funds.
Top
Guidelines
Applications and grants made under this funding opportunity will follow ASC's terms and conditions, which are in accordance with CIHR's terms and conditions for grants and awards as described in CIHR's Grants and Awards Guide.
Applications will be submitted to ASC, relevance and peer review will be managed jointly by ASC and CIHR, and funding decisions and grants will be released and managed by CIHR.
All conditions shall apply to applications funded through this funding opportunity. Conditions cover areas such as Applicant and Institutional Responsibilities, Ethics, Official Languages Policy, Access to Information and Privacy Acts, and Acknowledgement of Support.
Allowable costs
Collaborative Research to Action in Dementia grants may be used to support the following activities:
- networking and exchange activities specifically related to Canadian (or foreign) involvement in and contribution to foreign (or Canadian) initiatives and networks;
- travel, accommodations, workshop/seminar costs (e.g. audio-visual equipment, videoconferences), meeting rooms, hospitality costs (non-alcoholic refreshments or meals);
- design, implementation and evaluation of knowledge translation interventions (including innovation in the use of information technology), the development of methods, theories, and measures relevant to the study and evaluate interventions, research on theory and practice of knowledge translation; and/or
- demonstration projects to evaluate the implementation of an evidence-based approach (practice, tool, program, service, policy or product) as a viable solution to a known problem, and aimed at assessing the merits of widespread use of such an approach.
For more details, please view CIHR's allowable costs and activities under the Tri-Agency (CIHR, NSERC and SSHRC) financial administration guidelines Use of Grant Funds (Compensation-Related Expenses).
Communication Requirements
Grant recipients are required to acknowledge CIHR's Institute of Aging and the Alzheimer Society of Canada in any communication or publication related to the projects funded under this funding opportunity. See CIHR General Grants and Awards Policies, Public Communication and Acknowledgement of CIHR's Support for details on CIHR's communication requirements.
Top
Performance Measurement
N/A
Top
Review Process and Evaluation
Relevance Review process
Applications considered for funding will be those that are relevant to (in alignment with) the purpose of this funding opportunity.
The relevance of the applications will be determined prior to peer review. The relevance committee will be comprised of ASC and CIHR staff as well as in some cases, external delegates with expertise, as necessary.
The following set of criteria will be employed in conducting the relevance review.
- Extent to which the application aligns with the Cognitive Impairment in Aging Partnership initiative.
- Extent to which the application focuses on the translation of research in the fields of Alzheimer Disease and related Dementias into improved diagnosis, treatment and/or care.
Peer Review process
All applications to this funding opportunity will be evaluated by ASC's Quality of Life Review Panel through a peer review process that is in accordance with CIHR standards. Please refer to ASC guidelines.
The quality of the peer review and the appropriateness of the reviewers are the joint responsibility of ASC and CIHR.
Funding decisions on retained relevant applications to the Program will be based on their ranking based on peer review scores of the ASC's Quality of Life Review Panel, the funds available for this funding opportunity and level of relevance. In the case of funding decisions between two equally peer review scored applications, the degree of relevance will guide the selection.
Only applications receiving a score of 3.5 or greater will be considered for funding under this funding opportunity.
Upon completion of peer review of the full applications, CIHR-IA will receive the panel's scores and recommendations on the applicants from the ASC. The successful, relevant applications will be funded by CIHR-IA from the top down in order of score as far as the budget allows.
The evaluation criteria will be as follows.
1. Potential impact
- How likely is it that the proposed project will have an impact on advancing the translation of research or evidence in the fields of Alzheimer Disease and related Dementias into improved diagnosis, treatment and/or care?
- How important and original are the expected project outcomes?
- To what extent have the applicant(s) engaged relevant organizations for implementing the project and applying its findings?
- For international collaborations, is there is genuine Canadian (or foreign) involvement in and contribution to foreign (or Canadian) initiatives and networks and is the Canadian contribution appropriate?
- What is the potential for benefits to Canada, and if relevant, on an international scale?
2. Scientific rigour and feasibility
- How appropriate, pragmatic, and feasible are the project's design, timelines, and deliverables?
- How well have the applicants anticipated difficulties in their approach and considered alternatives?
- How critically has the relevant literature and pertinent information (e.g. environmental scans) been appraised and evaluated?
- Have the applicant(s) brought together the necessary expertise and collaborations to accomplish the work proposed?
3. Applicant(s) productivity, experience and training
- How appropriate to the proposed project is the training or track record of the applicant(s)? How important and original is the recent productivity of the applicant(s)? To what extent do the applicant(s) have the expertise and capacity to accomplish the proposed project?
- How much experience do the applicant(s) have in initiating and maintaining research partnerships with national, and where relevant international, researchers, initiatives, and networks?
Notification and Funding
Applicants will be informed by CIHR of the outcome of the competition. Grant payments will be issued by CIHR.
Top
How to Apply
Applications to this funding Opportunity must be submitted directly to the ASC.
The full Program Announcement with links to required application forms and submission information is available on the ASC Website.
Top
Contact Information
For questions and linkages with the network funded under the Research to Action Program in Dementia: the Canadian Dementia Knowledge Translation Network, contact:
Cathy MacNutt
Director
Canadian Dementia Knowledge Translation Network
Room 1427 - Veterans' Memorial Building
5995 Veterans' Memorial Lane
Halifax, NS B3H 3K2
Telephone: 902-473-4993
Fax: 902-473-1050
Email: cathy.macnutt@cdktn.ca
For questions on ASC guidelines and how to apply, contact:
Research Department
Alzheimer Society of Canada
20 Eglinton Ave. W., Ste. 1200
Toronto, ON M4R 1K8
Telephone: 416-847-2968
Fax: 416-488-3778
Email: research@alzheimer.ca
For questions on CIHR funding decisions and grant administration, contact:
Sophie Desjardins
Canadian Institutes of Health Research
Program Delivery Officer
Telephone: 613-954-6054
Fax: 613-954-1800
Email: sophie.desjardins@cihr-irsc.gc.ca
For questions about this initiative and its objectives, contact:
Linda Mealing
Assistant Director, Institute of Aging
Canadian Institutes of Health Research
Telephone: 613-952-4537
Fax: 613-954-1800
Email: linda.mealing@cihr-irsc.gc.ca
Top
Partner/Collaborator Description
Canadian Institutes of Health Research (CIHR)
CIHR is the Government of Canada's agency for health research. CIHR's mission is to create new scientific knowledge and to catalyze its translation into improved health, more effective health services and products, and a strengthened Canadian health-care system. Composed of 13 Institutes, CIHR provides leadership and support to more than 11,000 health researchers and trainees across Canada.
CIHR - Institute of Aging (IA)
The Institute of Aging (IA) supports research that promotes healthy aging and addresses causes, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions associated with aging. IA has identified five priority areas for research on aging and health: aging and maintenance of functional autonomy, biological mechanisms of aging, cognitive impairment in aging, healthy and successful aging, and health services and policy relating to older people.
Alzheimer Society of Canada (ASC)
Alzheimer Society of Canada (ASC) is a nation-wide federation of provincial organizations, local chapters, and support groups. The Society is dedicated to providing information and support to people living with Alzheimer Disease and other dementias, and to fostering research into biomedical and quality of life aspects of the disease. Through the Alzheimer Society Research Program, the Society offers training awards and research grants to scientists engaged in the study of causes, prevention, and treatment of Alzheimer Disease and other dementias.
Top
Additional Information
Research to Action Program in Dementia: The purpose of RAPID is to establish a nationally-focused network on a foundation of existing nodes of Alzheimer Disease and related dementias (ADRD) scientific excellence and knowledge translation expertise in Canada. The Network will facilitate and accelerate the translation of research in ADRD through the networking of researchers and relevant knowledge user communities and build capacity in these communities. In addition, it will address the health services gaps between research and practice in ADRD diagnosis, treatment and care and create knowledge for immediate needs through pilot research.
Top
| 
